On the recordFebruary 26, 2014
We have been talking about FDA's authority over the drug supply chain, the Drug Quality and Security Act.
Source
congress.govEditor's note · Context
Griffith expresses concern over FDA regulations affecting compounded drugs.
Share & report
More from Howard Griffith
Feb 26, 2025
Mr. Speaker, may I inquire as to how much time is remaining. The SPEAKER pro tempore (Mr. Begich). The gentleman from Virginia has 10 minutes remaining. The gentleman from New Jersey has 5\1/2\ minutes remaining.
Feb 26, 2025
When debating this resolution, H.J. Res. 35, is it appropriate to discuss superfluous matters to the matter at hand currently on the floor? The SPEAKER pro tempore. Under clause 1 of rule XVII, remarks in debate must be confined to the…
Apr 1, 2025
Mr. Speaker, I reserve the balance of my time, and I am prepared to close. Mr. McGOVERN. Mr. Speaker, I yield 1\1/2\ minutes to the gentlewoman from New Mexico (Ms. Stansbury).
Apr 1, 2025
Mr. Speaker, the gentlewoman apologized for the noises on the floor. I love the noises and greatly appreciate having babies around. Mr. Speaker, I yield 4 minutes to the gentlewoman from North Carolina (Ms. Foxx).
Other voices in this conversation
